|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Restructuring, severance and related costs | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income, net | |||||
| Debt issuance costs (Notes 7 and 8) | |||||
| Interest expense, net | |||||
| Loss before income taxes | |||||
| Income tax benefit, net | |||||
| Net loss | |||||
| Dividends on preferred stock - undeclared | |||||
| Deemed dividend on down round feature of warrants (Note 7) | |||||
| Net loss attributable to common stockholders | |||||
| Net loss per common share, basic (in dollars per share) | |||||
| Net loss per common share, diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding, basic (in shares) | |||||
| Weighted-average common shares outstanding, diluted (in shares) | |||||
Loading...